NEPTUNE Match Study

Part of paid clinical trials in Atlanta, Georgia.

Sponsor
University of Michigan
Study ID
NCT04571658
Status
Recruiting
Apply to this trial

Conditions

  • Alport Syndrome
  • FSGS
  • Focal Segmental Glomerulosclerosis
  • MCD
  • MCD - Minimal Change Disease
  • Membranous Nephropathy
  • Minimal Change Disease
  • Minimal Change Nephrotic Syndrome
  • Nephrotic Syndrome in Children

Eligibility Criteria

Sex
ALL
Age
1 Year - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Communication — OTHER
    The NEPTUNE Match study includes an interdisciplinary Communication Team that will translate findings from the Molecular Nephrology Board (MNB) to inform patients of the matching assessment with ongoing clinical trials. This team has considerable experience with conveying complex biomedical research information to patients and families and includes experts in precision nephrology, nephrology patient \[adult and pediatric\] communication, and health education.

Study Details

NEPTUNE Match is an additional opportunity offered to NEPTUNE study participants to prospectively recruit and communicate patient-specific clinical trial matching with kidney patients and their physician investigators.

Key Dates

Start date
May 2, 2022
Status verified
Jun 2026
Primary completion
Dec 30, 2029
Completion
Dec 30, 2029

Study Design

Enrollment
375 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Other: NEPTUNE Match Participants
    Approximately 375 participants will be consented from the NEPTUNE observational study with age and demographic groups representing the patient population in the NEPTUNE study site geographical areas. NEPTUNE observational cohort eligibility includes: participants in NEPTUNE observational cohort A are of any age and have a biopsy-confirmed diagnosis of Focal Segmental Glomerulosclerosis (FSGS), Minimal Change Disease (MCD), or Membranous Nephropathy (MN). Participants in NEPTUNE observational cohort B have documented NS based on proteinuria, serum albumin, and/or edema with age of onset less than 19 years.

Primary Outcome Measure

Matched participants with at least one clinical trial receive a MNB assessment [ Time Frame: 0-4 weeks ]

Central Contacts

Locations (16)

FacilityCityStateZIPSite coordinators
Emory University Hospital - Children's Hospital of AtlantaAtlantaGeorgia30322
Laurence Greenbaum, MD, PhD (PRINCIPAL_INVESTIGATOR)
John H. Stroger, Jr., Hospital of Cook CountyChicagoIllinois60612
Mathew Itteera
[email protected]
University of Kansas Medical CenterKansas CityKansas66160
Catherine Creed
[email protected]
Ellen McCarthy, MD (PRINCIPAL_INVESTIGATOR)
Johns Hopkins MedicineBaltimoreMaryland21287
MIahje Williams
[email protected]
Meredith Adkinson, MD (PRINCIPAL_INVESTIGATOR)
University of MichiganAnn ArborMichigan48109-
Children's Mercy HospitalKansas CityMissouri64108
Kelsey Markus
[email protected]
Tarak Srivastava, MD (PRINCIPAL_INVESTIGATOR)
Northwell/Cohen's Children's HospitalNew Hyde ParkNew York11040
Suzanne Vento, BSN
[email protected]
Christine Sethna, MD, MS (PRINCIPAL_INVESTIGATOR)
Columbia University Medical CenterNew YorkNew York10032
Anup Pradhan
Pietro Canetta, MD (PRINCIPAL_INVESTIGATOR)
University of North Carolina Chapel HillChapel HillNorth Carolina27514
Anne Froment
[email protected]
Maria Fernanda Ochoa Toro
[email protected]
Vimal Derebail, MD, MS (PRINCIPAL_INVESTIGATOR)
Cleveland Clinic FoundationClevelandOhio44106
Stefanie Larson
[email protected]
Katherine Dell, MD (PRINCIPAL_INVESTIGATOR)
Hospital of the University of PennsylvaniaPhiladelphiaPennsylvania19104
Krishna Kallem, MS
[email protected]
Larry Holzman, MD (PRINCIPAL_INVESTIGATOR)
Temple UniversityPhiladelphiaPennsylvania19122
Iris Lee, MD (PRINCIPAL_INVESTIGATOR)
Medical University of South CarolinaCharlotteSouth Carolina29425
David Selewski, MD, MS (PRINCIPAL_INVESTIGATOR)
Seattle Children's HospitalSeattleWashington98105
Sangeeta Hingorani, MD (PRINCIPAL_INVESTIGATOR)
University of Washington Medical CenterSeattleWashington98195
Linda Manahan, BSN
[email protected]
Ashley Jefferson, MD (PRINCIPAL_INVESTIGATOR)
Providence Sacred Heart Medical CenterSpokaneWashington99204
Kelli Kuykendall
[email protected]
Katherine Tuttle, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Atlanta, GA

By research site
Emory University Hospital - Children's Hospital of Atlanta· Atlanta, GAJohn H. Stroger, Jr., Hospital of Cook County· Chicago, ILUniversity of Kansas Medical Center· Kansas City, KSJohns Hopkins Medicine· Baltimore, MDUniversity of Michigan· Ann Arbor, MIChildren's Mercy Hospital· Kansas City, MO

Related Studies